Vitrafy Life Sciences Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Vitrafy Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $2.70. The average 1-year stock price forecast is 1.46% lower than the current stock price, while the lowest is $2.41 (-12.04%) and the highest is $3.00 (+9.49%).

Price Target: $2.70 (-1.46%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.41	$2.70	$2.70	$3.00
Change	-12.04%	-1.46%	-1.46%	+9.49%

* Price targets were last updated on Apr 29, 2026.

Analyst Ratings

The average analyst rating for Vitrafy Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Martyn Jacobs Bell Potter	Bell Potter	Buy Maintains $2.25 → $3.00	Buy	Maintains	$2.25 → $3.00	+9.49%	Apr 29, 2026
Tom Godfrey Ord Minnett	Ord Minnett	Buy Maintains $2.50 → $2.40	Buy	Maintains	$2.50 → $2.40	-12.41%	Mar 24, 2026

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.